The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

GMAB FINANCIAL STATEMENTS

Genmab AS — balance sheet, income statement and cash flow trends

GMABGenmab AS

🇺🇸 USA · US · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
05 B10 B15 B20202021202220232026

Profit Funnel

Q2 2026 · TTM
Revenue4.1 B $Gross Profit3.8 B $ · 93%Operating Income1.3 B $ · 32%Pre-tax Income906.1 M $ · 22%Net Income to Owners788.1 M $ · 19%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue4.1 B $-68.2%
Gross Profit3.8 B $-68.9%
Operating Income1.3 B $-71.3%
EBITDA1.2 B $-75.8%
Net Income to Owners788.1 M $-85.6%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
020 B40 B20202021202220232026

Capital Structure

Q2 2026
Total Assets12.5 B
  • Equity6 B $48%
  • Current Liabilities1.1 B $9%
  • Long-term Liabilities5.4 B $43%

Key Figures

YoY change
Total Assets12.5 B $+93.7%
Total Liabilities6.6 B $+464.5%
Total Equity6 B $+12.4%
Cash & ST Investments1.5 B $-48.1%
Total Debt5.3 B $+3,463.6%
Net Debt3.8 B $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
02.5 B5 B7.5 B20202021202220232026

Cash Flow Bridge

Q2 2026 · TTM
-4 B-2 B0890.3 M $Operating-5.6 B $Investing5 B $Financing212.9 M $Net Change

Key Figures

YoY change
Operating Cash Flow890.3 M $-67.1%
Capital Expenditures23 M $-80.0%
Free Cash Flow867.3 M $-66.6%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on GMAB

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.